ABIVAX valuation
€63.00Change from previous close: −17.21%Absolute change: −€13.10
Valuation
The average price target of 7 analysts is €131.72.
Data as of November 22, 2026
ABIVAX compared with similar companies
ABIVAX's Price/book: 13.7, +165% against the median of a group of 10 similar companies (5.18).
| Metric | ABIVAX | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Price/book | 13.7 | 5.18 | 1.90 – 8.46 | High |
| Gross margin | 100.0% | 68.1% | 41.2% – 93.2% | High |
| Operating margin | -6,270.4% | 21.8% | 9.0% – 34.0% | Low |
| Net margin | 0.0% | 19.9% | 5.3% – 27.8% | Low |
| ROE | -252.3% | 12.2% | 7.9% – 18.4% | Low |
| Debt/equity | 0.00 | 0.02 | 0.01 – 0.06 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- €5.52B
- Enterprise value
- €4.63B
- P/E (trailing 12 months)
- -15.2
- Forward P/E
- -21.7
- Price/sales
- 1,181.5
- EV/EBITDA
- -15.9
- EV/revenue
- 991.3
Profitability and growth
- ROA
- -62.9%
- ROIC
- -87.5%
- Revenue growth (year over year)
- -6.8%
- Earnings growth (year over year)
- 93.2%
Financial health
- Total cash
- €402.38M
- Total debt
- €1.21M
- Current ratio
- 5.97
- Quick ratio
- 5.79
- Altman Z-Score
- 37.7
- Piotroski F-Score
- 2.00
Dividends
- Dividend yield
- 0.0%
Analysts and estimates
- Average price target
- €131.72
- Median price target
- €131.00
- High price target
- €180.00
- Low price target
- €70.00
- Analysts with a price target
- 7
- Consensus
- Buy
- Forward EPS
- -€2.90
- EPS estimate, current year
- -€3.53
Shares and trading
- Beta
- -0.33
- Average volume
- 132.79K
- Shares outstanding
- 87.54M
- Float
- 70.84M
- Institutional ownership
- 53.0%
- Insider ownership
- 4.5%
